Health Condition 1: C501- Malignant neoplasm of central portion of breast Health Condition 2: C503- Malignant neoplasm of lower-innerquadrant of breast Health Condition 3: C505- Malignant neoplasm of lower-outerquadrant of breast Health Condition 4: C500- Malignant neoplasm of nipple and areola Health Condition 5: C508- Malignant neoplasm of overlappingsites of breast Health Condition 6: C502- Malignant neoplasm of upper-innerquadrant of breast Health Condition 7: C504- Malignant neoplasm of upp
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
Intramural Fund, MAHE, Manipal
Eligibility
Inclusion criteria
Inclusion criteria: 1. Newly diagnosed female breast cancer patients 2. Patients scheduled for Modified Radical Mastectomy (MRM) or Breast Conservative Surgery (BCS). 3. Patients who are willing to give informed consent. 4. Patients above the age of 18 years.
Exclusion criteria
Exclusion criteria: 1. Vulnerable patients 2. HIV, TB, Hepatitis positive patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) Outcome measures used in this research comprise of demographic and clinical data, histopathology and diagnostic tests reports and descriptions of various treatment regimens used. 2) mRNA expressions of UHRF1 3) mRNA expressions of EZH2 4) mRNA expressions of UBL5 Timepoint: 3 Years | — |
Secondary
| Measure | Time frame |
|---|---|
| Correlating sociodemographic and clinicopathological parameters with the mRNA expressions of UHRF1, EZH2 and UBL5.Timepoint: 3 Years | — |
Countries
India
Contacts
Public ContactDr Naveena AN Kumar
Manipal College of Pharmaceutical Sciences, MAHE, Manipal
Outcome results
None listed